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Abstract: Objective: To evaluate the expression of VEGF by chondrocytes
 of hyaline cartilage during the course of 
osteoarthritis (OA).
 
Methods: In 12 white New Zealand rabbits the anterior cruciate
  ligament (ACL) was resected to create an anterior 
instability
 of the knee. In 12 control rabbits only a sham operation without
 resection of the ACL was done. Four animals of 
each group were
 killed at 3, 6, and 12 weeks. The load bearing area was evaluated
 histologically according to Mankin and 
by immunostaining for
 VEGF. 
Results: In the experimental group, histological grades of OA showed
 a positive linear correlation with the time after 
surgery. Immunostaining
 showed an increased expression of VEGF in the control group
 after 3 weeks, which dropped to 
normal after 6 weeks.
 There was no difference in the progression of OA between control and experimental groups after
 3 
weeks, but a significant difference was seen after 6 (p=0,01) and 12 (p=0,05) weeks. A significant
 positive correlation 
between VEGF expression and the histological
 grade of OA was found (r = 0.767; p<0.01).
 
Conclusions: An increase of VEGF expressing chondrocytes occurs during time course of OA. 
Keywords: VEGF, animal experiments, osteoarthritis. 
INTRODUCTION 
  Osteoarthritis is a degenerative disease of the hyaline 
cartilage of the articular surfaces, directly related to ageing 
and mechanical damage [1], resulting in matrix degradation 
[2, 3]. Several studies of late stage arthritis showed that 
VEGF is expressed in osteoarthritis [4-6], indicating that 
angiogenesis might be involved in the pathology of OA. In 
fact, in severe arthritis [7], angiogenesis has been observed. 
Little is known about
 the time depended expression of VEGF 
during the time course of OA.
 This study was designed to 
evaluate (a) the time depending expression of VEGF during 
the course of OA and (b) possible correlations
  with 
histological findings.
 
MATERIAL AND METHODS 
Animals, Surgery and Macroscopic Evaluation 
  The experiments were performed with permission of the 
local
  government (G49/2000) in accordance with National 
Institute of Health (NIH)
 guidelines as described earlier [8]. 
Briefly, twenty eight fully grown, female white
 New Zealand 
rabbits were used. In the experimental group (12 animals), 
the anterior cruciate ligament was resected to create 
instability of the knee. In the control group (12 animals),   
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only a sham operation without resection of the ACL was 
done. Four animals
 of each group were killed at 3, 6, and 12 
weeks postoperatively. In addition, four animals (0 weeks) 
did not undergo any treatment and
 were killed at the time of 
surgery. After slaying the animals, both distal
 femurs were 
prepared and immediately stored at –80°C. Macroscopic 
grading of arthritis was done as described previously [8]. 
Histological Evaluation 
  Sample preparation and immunostaining were performed 
as described earlier [8], with some modifications. Briefly, 
frozen tissue samples were thawed, fixed
  with 4% 
paraformaldehyde, decalcificated using buffered EDTA 
(20%, pH 7.4), dehydrated and embedded in paraffin. 
Sections
 (5 m thick) were cut, mounted on poly-L-lysine 
coated
  glass slides, deparaffinized in xylene, and washed. 
Epitope unmasking was done using proteinase K digestion 
(DAKO, Germany) for 5 minutes and endogenous 
peroxidase activity was quenched by treating tissue
 sections 
with 3% H2O2 for 10 minutes, non-specific binding was 
blocked using 3% bovine serum albumin (BSA/TrisHCl), 
each followed by an excessive washing procedure. Sections 
thus prepared were incubated with monoclonal mouse
 IgG 
antibodies against VEGF diluted 1:50 in Tris/BSA 
(Calbiochem Clone JH 121) at 4°C over night. Visualization 
was done using EnVision+ System- HRP with AEC-
chromogene (DAKO Envision Systems, Germany, K4001). 
As control instead of primary antibody, mouse IgG1
  with 
irrelevant specificity (Aspergillus niger glucose oxidase,
 178    The Open Orthopaedics Journal, 2011, Volume 5  Tibesku et al. 
DAKO, Germany) was used. In addition, sections were 
incubated without
 primary antibody. 
Image Analysis 
  Histological sections were photographed (CoolSnap-Pro 
Color
  A00J82025, Media Cybernetics, Silver Spring, MD, 
USA). The cells
  were counted using the Image-Pro Plus 
software for Windows,
  version 4.1 (Media Cybernetics, 
Silver Spring, MD, USA). The
 total number of chondrocytes 
was determined in a hematoxylin
 and eosin stained section 
and compared with the number of immunohistochemically
 
stained cells.
 
  Histological grade of OA was evaluated according to
 
Mankin [9] by two independent investigators who were
 
unaware of the source of the specimens. The sections were 
decalcified by using EDTA which leads to an adapted 
mankin score which we used in the present study. 
Statistical Analysis 
  Statistical analysis was performed using SPSS 11.0 
(SPSS GmbH,
 Munich, Germany). Student’s t test was used 
for comparison
  of scores, and Spearman´s coefficient was 
calculated for
  correlations.
  P values less then 0.05 were 
considered significant. 
RESULTS 
  Two animals developed postoperative hematomas, first a 
superficial
  wound infection treated with a single shot 
antibiotic, and second
  animal wound gap re-operated on 2 
days after surgery. All four
  animals were included in the 
analysis. At the time of death,
 one animal of group one had 
intact ACLs and was excluded from
 evaluation. In total, 54 
joints were evaluated.
 
Histological Grading of OA 
  According to the Mankin score, the experimental group 
showed a highly significant
 increase in the grade of OA in 
comparison with the control group and the untreated group 
(Figs. 3-6). In the untreated group the mean (SD) grade of 
OA was 1.75 (1.58). In
 the control group it was 3.25 (0.71) 
after 3 weeks, 1 (1.20) after 6 weeks,
 and 2.25 (1.17) after 12 
weeks. In the experimental group, the scores were 7.25
 
(3.62) after 3 weeks, 8 (2.88) after 6 weeks, and 9.83 (3.06)
 
after 12 weeks. The experimental group had significantly 
higher values than
 the control group
 at every point of time 
(p<0.01). The average histological
  grade of OA increased 
with the number of postoperative weeks.
 It is remarkable that 
in the control group the histological grading increases within 
the first three weeks and drops to normal in the following 
time. 
Immunohistochemical Staining of VEGF 
  Chondrocytes expressing VEGF were found in the 
experimental and control
  groups (Fig. 1). In the control 
group, the mean percentage (SD) of VEGF positive cells was 
16.2 ± 4.7 % after 3 weeks, 11.5 ± 5.9 % after 6 weeks, and 
11.6  ± 3.3  % after 12 weeks. In the experimental group, 
percentages were 17.7 ± 5.7 % after 3 weeks,
 19.4 ± 4.6 % 
after 6 weeks, and 21.3  ±  5.4  % after 12 weeks (Fig. 1 ).
 
There was no significant difference between control and 
experimental groups after
  3 weeks (p= 0.594), but a 
significant difference was seen after 6 and 12 weeks (p=0.01 
and p=0.05). It is remarkable that in the control group the 
percentage of VEGF expressing chondrocytes increases 
within the fist three weeks and drops to normal in the 
following time. 
 
Fig. (1). Time course of the development of VEGF expression in 
osteoarthritis (light bar presents the sham operation, grey bar the acl 
resection group). The percentage of VEGF expressing chondrocytes 
was significantly increased in the ACL resection group after 6 
(p=0.01) and 12 (p=0.05) weeks. Data represent mean ± SD from 4 
independent determinations. 
 
Fig. (2). Correlation between the histological and macroscopic grade of osteoarthritis (OA) with expression of VEGF by chondrocytes. 
Significant positive correlations were found with a Spearman´s coefficient of 0.767 (p=0.01) and 0.518 (p=0.02). 
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  A significant correlation was found between the 
percentage of
  VEGF positive chondrocytes and the 
histological grade (r =
  0.767, p = 0.01) as well as the 
macroscopic grade (r =
 0.518, p = 0.02) (Fig. 2). Focusing on 
osteophyte formation (as part of the macroscopic grade) a 
positive correlation (r = 0.651; p< 0.01) was detectable. The 
VEGF staining occurred throughout the cartilage. 
DISCUSSION 
  The present study demonstrates that VEGF is synthesized 
by chondrocytes of articular cartilage in knees of healthy 
rabbits. With the development of osteoarthritis due to ACL 
resection this ratio alters, resulting in an increase of VEGF 
expressing chondrocytes, correlating with the degree of 
osteoarthritis. Therefore, the expression of VEGF might be a 
useful marker of OA. Our data, obtained in an experimental 
animal model, corresponds with findings of others [4-6, 10, 
11] who found that VEGF expression is up regulated in 
human chondrocytes during late stage OA. 
  Osteophyte formation and extension of the subchondral 
growth plate have been observed in OA and involve 
processes very similar to enchondral ossification, which is 
highly dependent on VEGF [12]. In our studies, the amount 
of VEGF producing chondrocytes was positively correlated 
with the osteophyte formation. A methodological limitation 
of our study is that we mixed the values of sham and ACLT 
in the statistic which could influence the present results. 
 
Fig. (3). Immunohistochemical staining of VEGF, 3 weeks after sham operation (left side) and 3 weeks after resection of the anterior cruciate 
ligament (right side). 
 
Fig. (4). Immunohistochemical staining of VEGF, 6 weeks after sham operation (left side) and 6 weeks after resection of the anterior cruciate 
ligament (right side). 
 
Fig. (5). Immunohistochemical staining of VEGF, 12 weeks after sham operation (left side) and 12 weeks after resection of the anterior 
cruciate ligament (right side). 180    The Open Orthopaedics Journal, 2011, Volume 5  Tibesku et al. 
 
Fig. (6). 12 weeks after acl resection showing pronounced 
osteophytes and exposure of the subchondral cartilage zone. 
  Focusing on the time course of the control group, three 
weeks after surgery the percentage of VEGF expressing 
chondrocytes increases although no mechanic instability was 
induced by ACL resection. This might be due to angiogenic 
process common in wound healing [13, 14]. Nevertheless, it 
is remarkable that the histological grading according to 
Mankin is raised after 3 weeks and drops to normal in the 
following time, comparable to the percentage of VEGF 
expressing chondrocytes. This might be interpreted that 
VEGF alone has a negative impact on the integrity of the 
articular cartilage as postulated by Pufe [15]. This finding 
has far reaching consequences; for antiangiogenic therapy 
might be expedient in the treatment of osteoarthritis. Further 
studies are needed to evaluate VEGF as a target in 
osteoarthritis treatment. 
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ABBREVIATIONS 
ACL  =  Anterior cruciate ligament 
OA =  Osteoarthritis 
VEGF  =  Vascular endothelial growth factor 
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